FGFR3 unliganded dimer stabilization by the juxtamembrane domain

Journal of Molecular Biology

Volumn 427, Issue 8, 2015, Pages 1705-1714

  Sarabipour, Sarvenaz ^a   Hristova, Kalina ^a  

^a Johns Hopkins University   (United States)

Author keywords

Juxtamembrane domain; Membrane protein dimerization; Receptor tyrosine kinases; Thermodynamics; Transmembrane domain

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; GLYCOPHORIN A; FGFR3 PROTEIN, HUMAN; SIGNAL PEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; CELL MEMBRANE; CHO CELL LINE; CONTROLLED STUDY; DIMERIZATION; FEMALE; FLUORESCENCE; GENE MUTATION; JUXTAMEMBRANE DOMAIN; LIGAND BINDING; MEMBRANE VESICLE; NONHUMAN; OSMOTIC STRESS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; RESTRICTION SITE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; CRICETULUS; GENETICS; HUMAN; MOLECULAR GENETICS; POINT MUTATION; PROTEIN MULTIMERIZATION; THERMODYNAMICS;

AMINO ACID SEQUENCE; ANIMALS; CHO CELLS; CRICETULUS; HUMANS; MOLECULAR SEQUENCE DATA; POINT MUTATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN SORTING SIGNALS; PROTEIN STABILITY; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; THERMODYNAMICS;

EID: 84933041582     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2015.02.013     Document Type: Article

References (44)

1. Wells A. EGF receptor. Int J Biochem Cell Biol 1999;31: 637-43.
2. Linggi B, Carpenter G. ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol 2006;16:649-56.
3. Grandis JR, Sok JC. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacol Ther 2004;102:37-46.
4. Fantl WJ, Johnson DE, Williams LT. Signaling by receptor tyrosine kinases. Annu Rev Biochem 1993;62:453-81.
5. Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010;141:1117-34.
6. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000;103:211-25.
7. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005;16:139-49.
8. Schlessinger J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 2004;306: 1506-7.
9. Zhang XW, Gureasko J, Shen K, Cole PA, Kuriyan J. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 2006;125:1137-49.
10. Low-Nam ST, Lidke KA, Cutler PJ, Roovers RC, van Bergen en Henegouwen PM, Wilson BS, et al. ErbB1 dimerization is promoted by domain co-confinement and stabilized by ligand binding. Nat Struct Mol Biol 2011;18:1244-9.
11. Endres NF,Das R, SmithAW, Arkhipov A, Kovacs E, Huang YJ, et al. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 2013;152:543-56.
12. Shen JY, Maruyama IN. Nerve growth factor receptor TrkA exists as a preformed, yet inactive, dimer in living cells. FEBS Lett 2011;585:295-9.
13. Maruyama I, Shen JY. Brain-derived neurotrophic factor receptor TrkB exists as a preformed dimer in living cells. FASEB J 2012;26:971.8.
14. Lin CC, Melo FA, Ghosh R, Suen KM, Stagg LJ, Kirkpatrick J, et al. Inhibition of basal FGF receptor signaling by dimeric Grb2. Cell 2012;149:1514-24.
15. Belov AA, Mohammadi M. Grb2, a double-edged sword of receptor tyrosine kinase signaling. Sci Signal 2012;5:pe49.
16. He L, Hristova K. Physical-chemical principles underlying RTK activation, and their implications for human disease. Biochim Biophys Acta 2012;1818:995-1005.
17. Li E, Hristova K. Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies. Biochemistry 2006;45:6241-51.
18. Jura N, Endres NF, Engel K, Deindl S, Das R, Lamers MH, et al. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 2009;137: 1293-307.
19. Arkhipov A, Shan YB, Das R, Endres NF, Eastwood MP, Wemmer DE, et al. Architecture and membrane interactions of the EGF receptor. Cell 2013;152:557-69.
20. Vajo Z, Francomano CA, Wilkin DJ. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 2000;21:23-39.
21. Horton WA, Hall JG, Hecht JT. Achondroplasia. Lancet 2007; 370:162-72.
22. Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet 1995;11:462-4.
23. Li Y, Mangasarian K, Mansukhani A, Basilico C. Activation of FGF receptors by mutations in the transmembrane domain. Oncogene 1997;14:1397-406.
24. He L, Horton WA, Hristova K. The physical basis behind achondroplasia, the most common form of human dwarfism. J Biol Chem 2010;285:30103-14.
25. He LJ, Serrano C, Niphadkar N, Shobnam N, Hristova K. Effect of the G375C and G346E achondroplasia mutations on FGFR3 activation. PLoS One 2012;7:e34808.
26. Chen F, Sarabipour S, Hristova K. Multiple consequences of a single amino acid pathogenic RTK mutation: the A391E mutation in FGFR3. PLoS One 2013;8:e56521.
27. Chen L, Placone J, Novicky L, Hristova K. The extracellular domain of fibroblast growth factor receptor 3 inhibits ligandindependent dimerization. Sci Signal 2010;3:ra86.
28. Evers TH, van Dongen EMWM, Faesen AC, Meijer EW, Merkx M. Quantitative understanding of the energy transfer between fluorescent proteins connected via flexible peptide linkers. Biochemistry 2006;45:13183-92.
29. Del Piccolo N, Placone J, He L, Agudelo SC, Hristova K. Production of plasma membrane vesicles with chloride salts and their utility as a cell membrane mimetic for biophysical characterization of membrane protein interactions. Anal Chem 2012;84:8650-5.
30. Chen L, Novicky L, Merzlyakov M, Hristov T, Hristova K. Measuring the energetics of membrane protein dimerization in mammalian membranes. J Am Chem Soc 2010;132: 3628-35.
31. Scott RE, Maercklein PB. Plasma-membrane vesiculation in 3T3 cells and Sv3T3 cells. 2. Factors affecting the process of vesiculation. J Cell Sci 1979;35:245-52.
32. Scott RE, Perkins RG, Zschunke MA, Hoerl BJ, Maercklein PB. Plasma-membrane vesiculation in 3T3 cells and Sv3T3 cells. 1. Morphological and biochemical characterization. J Cell Sci 1979;35:229-43.
33. Scott RE. Plasma membrane vesiculation: a new technique for isolation of plasma membrane. Science 1976;194:743-5.
34. Lemmon MA, Treutlein HR, Adams PD, Brünger AT, Engelman DM. A dimerization motif for transmembrane alpha-helices. Nat Struct Biol 1994;1:157-63.
35. Hong H, Bowie JU. Dramatic destabilization of transmembrane helix interactions by features of natural membrane environments. J Am Chem Soc 2011;133:11389-98.
36. Sarabipour S, Hristova K. FGFR3 transmembrane domain interactions persist in the presence of its extracellular domain. Biophys J 2013;105:165-71.
37. Tanner KG, Kyte J. Dimerization of the extracellular domain of the receptor for epidermal growth factor containing the membrane-spanning segment in response to treatment with epidermal growth factor. J Biol Chem 1999;274:35985-90.
38. Grasberger B, Minton AP, DeLisi C, Metzger H. Interaction between proteins localized in membranes. Proc Natl Acad Sci U S A 1986;83:6258-62.
39. He L, Hristova K. Consequences of replacing EGFR juxtamembrane domain with an unstructured sequence. Sci Rep 2012;2:854.
40. Robertson SC, Tynan JA, Donoghue DJ. RTK mutations and human syndromes-when good receptors turn bad. Trends Genet 2000;16:265-71.
41. Chen LI, Webster MK, Meyer AN, Donoghue DJ. Transmembrane domain sequence requirements for activation of the p185(c-neu) receptor tyrosine kinase. J Cell Biol 1997;137: 619-31.
42. Webster MK, Donoghue DJ. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J 1996;15:520-7.
43. Sarabipour S, King C, Hristova K. Un-induced high-yield bacterial expression of fluorescent proteins. Anal Biochem 2014;449:155-7.
44. Li E, Placone J, Merzlyakov M, Hristova K. Quantitative measurements of protein interactions in a crowded cellular environment. Anal Chem 2008;80:5976-85.